Better insights & faster testing for safer radiopharmaceutical therapies
Quality assurance that delivers comprehensive insights in minutes, not hours – improving patient safety and treatment outcomes.
Supported by
Comprehensive analysis in one scan
Other devices provide visibility only on alpha, beta, or gamma radiation, while Lyla offers full insight into the radiopharmaceutical's complete composition.
Lab-friendly and safe operation
Unlike other devices, which often require separate detectors and a fume hood, Lyla captures radiation in a sealed cartridge, reducing contamination risks and improving lab safety.
Free up valuable lab space
With a compact design and integrated functionality, this system eliminates the need for multiple devices and a fume hood, maximizing lab space and streamlining operations.
Lab work just got easier
Lab work shouldn't be complicated. We've designed Lyla to simplify your workflow, delivering accurate results with less effort.
HARDWARE
LYLA TLC Scanner
The Lyla TLC Scanner is a compact device designed for radiopharmaceutical labs. You simply insert the cartridge, press start, and receive a complete radiation profile in one scan, including direct measurement of alpha radiation. There's no need for fume hoods, manual cutting of TLC strips, or switching between detectors. Lyla streamlines your workflow into a fast, consistent, and safe procedure.
SOFTWARE
LYLA Quality Suite
The LYLA Quality Suite is designed to support each scan with a clear and consistent workflow, from loading the cartridge to reviewing the results. It helps store your data, visualize outcomes, and generate structured reports with key insights. Built around common lab procedures, it’s made to guide you through the process with minimal effort and maximum clarity.
In the news
Lyla (previously Alphapace) proudly won the Philips Innovation Award 2024 in the Rough Diamond category, selected from 175 entries. This recognition highlights our innovative contribution to advancing healthcare and radiopharmaceutical quality testing.
Lyla (previously Alphapace) is honored to have received the Life Science Award, sponsored by BioPartner Leiden and Gulliver, recognizing our groundbreaking work in radiopharmaceuticals and our commitment to driving progress in this vital field.
